KLF9 and glioblastoma: These findings highlight KLF9’s dual role as both a differentiation driver and a suppressor of Notch1-mediated oncogenic signaling in GBM stem cells, linking its activity to diminished tumor propagation and stem cell plasticity (41, 42).